SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the rapidly evolving RNA virus behind the COVID-19 pandemic, has spawned numerous variants since its 2019 emergence. The multifunctional NSP14 enzyme, possessing exonuclease and mRNA capping capabilities, serves as a key player. Notably, single and co-occurring mutations within NSP14 significantly influence replication fidelity and drive variant diversification. This study comprehensively examines 120 co-mutations, 68 unique mutations, and 160 conserved residues across NSP14 homologs, shedding light on their implications for phylogenetic patterns, pathogenicity, and residue interactions. Quantitative physicochemical analysis categorizes 3953 NSP14 variants into three clusters, revealing genetic diversity. This research underscores the dynamic nature of SARS-CoV-2 evolution, primarily governed by NSP14 mutations. Understanding these genetic dynamics provides valuable insights for therapeutic and vaccine development..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 04. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hassan, Sk. Sarif [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.09.28.559966 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI040987477 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI040987477 | ||
| 003 | DE-627 | ||
| 005 | 20231205144108.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231002s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.09.28.559966 |2 doi | |
| 035 | |a (DE-627)XBI040987477 | ||
| 035 | |a (biorXiv)10.1101/2023.09.28.559966 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hassan, Sk. Sarif |e verfasserin |0 (orcid)0000-0003-4331-722X |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the rapidly evolving RNA virus behind the COVID-19 pandemic, has spawned numerous variants since its 2019 emergence. The multifunctional NSP14 enzyme, possessing exonuclease and mRNA capping capabilities, serves as a key player. Notably, single and co-occurring mutations within NSP14 significantly influence replication fidelity and drive variant diversification. This study comprehensively examines 120 co-mutations, 68 unique mutations, and 160 conserved residues across NSP14 homologs, shedding light on their implications for phylogenetic patterns, pathogenicity, and residue interactions. Quantitative physicochemical analysis categorizes 3953 NSP14 variants into three clusters, revealing genetic diversity. This research underscores the dynamic nature of SARS-CoV-2 evolution, primarily governed by NSP14 mutations. Understanding these genetic dynamics provides valuable insights for therapeutic and vaccine development. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Bhattacharya, Tanishta |4 aut | |
| 700 | 1 | |a Nawn, Debaleena |4 aut | |
| 700 | 1 | |a Jha, Ishana |4 aut | |
| 700 | 1 | |a Basu, Pallab |4 aut | |
| 700 | 1 | |a Redwan, Elrashdy M. |4 aut | |
| 700 | 1 | |a Lundstrom, Kenneth |4 aut | |
| 700 | 1 | |a Barh, Debmalya |4 aut | |
| 700 | 1 | |a Andrade, Bruno Silva |4 aut | |
| 700 | 1 | |a Tambuwala, Murtaza M. |4 aut | |
| 700 | 1 | |a Aljabali, Alaa A. |4 aut | |
| 700 | 1 | |a Hromić-Jahjefendić, Altijana |4 aut | |
| 700 | 1 | |a Baetas-da-Cruz, Wagner |4 aut | |
| 700 | 1 | |a Uversky, Vladimir N. |0 (orcid)0000-0002-4037-5857 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 04. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:04 |g month:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.09.28.559966 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 04 |c 10 | ||